ATAIAtaiBeckley Inc.
- Market cap
- not reported
- Latest close
- not reported
- Sector
- Healthcare
- as of 2026-10-24
- Industry
- Biotechnology
- as of 2026-10-24
Values marked — are missing or out of date.
Cluster
No cluster in the last 90 days under the default rule (14d · ≥2 insiders · all roles).
Form 4 historysince 2026-01-06
| Insider | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Angermayer Christian | Sep 11 | Sep 11 | D | 559,232 | not reported | not reported | not reported | No | Form 4 |
| Angermayer Christian | Sep 11 | Sep 11 | D | 53,398,214 | not reported | not reported | not reported | No | Form 4 |
| Angermayer Christian | Sep 11 | Sep 11 | D | 1,799,302 | not reported | not reported | not reported | No | Form 4 |
| Angermayer Christian | Sep 11 | Sep 11 | D · derivative | 624,000 | $5.68 | $3,544,320 | not reported | No | Form 4 |
| Angermayer Christian | Sep 11 | Sep 11 | D · derivative | 64,000 | $3.84 | $245,760 | not reported | No | Form 4 |
| Angermayer Christian | Sep 11 | Sep 11 | D · derivative | 17,930 | $1.88 | $33,708 | not reported | No | Form 4 |
| Angermayer Christian | Sep 11 | Sep 11 | D · derivative | 1,247,932 | $1.64 | $2,046,608 | not reported | No | Form 4 |
| Angermayer Christian | Sep 11 | Sep 11 | D · derivative | 131,698 | $2.49 | $327,928 | not reported | No | Form 4 |
| Angermayer Christian | Sep 11 | Sep 11 | D · derivative | 103,000 | $2.25 | $231,750 | not reported | No | Form 4 |
| Angermayer Christian | Sep 11 | Sep 11 | D · derivative | 121,968 | $4.50 | $548,856 | not reported | No | Form 4 |
| Johnson Sabrina Martucci | Sep 11 | Sep 11 | D · derivative | 64,000 | $3.84 | $245,760 | not reported | No | Form 4 |
| Johnson Sabrina Martucci | Sep 11 | Sep 11 | D · derivative | 64,000 | $1.88 | $120,320 | not reported | No | Form 4 |
| Johnson Sabrina Martucci | Sep 11 | Sep 11 | D · derivative | 103,000 | $1.34 | $138,020 | not reported | No | Form 4 |
| Johnson Sabrina Martucci | Sep 11 | Sep 11 | D · derivative | 103,000 | $2.25 | $231,750 | not reported | No | Form 4 |
| Johnson Sabrina Martucci | Sep 11 | Sep 11 | D · derivative | 121,968 | $4.50 | $548,856 | not reported | No | Form 4 |
| Hershberg Robert | Sep 11 | Sep 11 | D · derivative | 48,858 | $1.35 | $65,958 | not reported | No | Form 4 |
| Hershberg Robert | Sep 11 | Sep 11 | D · derivative | 404,869 | $1.35 | $546,573 | not reported | No | Form 4 |
| Hershberg Robert | Sep 11 | Sep 11 | D · derivative | 62,394 | $1.35 | $84,232 | not reported | No | Form 4 |
| Hershberg Robert | Sep 11 | Sep 11 | D · derivative | 103,000 | $4.48 | $461,440 | not reported | No | Form 4 |
| Hershberg Robert | Sep 11 | Sep 11 | D · derivative | 121,968 | $4.50 | $548,856 | not reported | No | Form 4 |
| Braunstein Scott | Sep 11 | Sep 11 | D · derivative | 206,000 | $1.34 | $276,040 | not reported | No | Form 4 |
| Braunstein Scott | Sep 11 | Sep 11 | D · derivative | 103,000 | $2.25 | $231,750 | not reported | No | Form 4 |
| Braunstein Scott | Sep 11 | Sep 11 | D · derivative | 56,818 | $5.28 | $299,999 | not reported | No | Form 4 |
| Braunstein Scott | Sep 11 | Sep 11 | D · derivative | 208,063 | $4.50 | $936,284 | not reported | No | Form 4 |
| Smiley Andrea Heslin | Sep 11 | Sep 11 | D | 4,666 | not reported | not reported | not reported | No | Form 4 |
| Smiley Andrea Heslin | Sep 11 | Sep 11 | D · derivative | 64,000 | $3.84 | $245,760 | not reported | No | Form 4 |
| Smiley Andrea Heslin | Sep 11 | Sep 11 | D · derivative | 64,000 | $1.88 | $120,320 | not reported | No | Form 4 |
| Smiley Andrea Heslin | Sep 11 | Sep 11 | D · derivative | 103,000 | $1.34 | $138,020 | not reported | No | Form 4 |
| Smiley Andrea Heslin | Sep 11 | Sep 11 | D · derivative | 103,000 | $2.25 | $231,750 | not reported | No | Form 4 |
| Smiley Andrea Heslin | Sep 11 | Sep 11 | D · derivative | 121,968 | $4.50 | $548,856 | not reported | No | Form 4 |
| Kalali Amir H | Sep 11 | Sep 11 | D | 4,666 | not reported | not reported | not reported | No | Form 4 |
| Kalali Amir H | Sep 11 | Sep 11 | D · derivative | 64,000 | $3.84 | $245,760 | not reported | No | Form 4 |
| Kalali Amir H | Sep 11 | Sep 11 | D · derivative | 64,000 | $1.88 | $120,320 | not reported | No | Form 4 |
| Kalali Amir H | Sep 11 | Sep 11 | D · derivative | 103,000 | $1.34 | $138,020 | not reported | No | Form 4 |
| Kalali Amir H | Sep 11 | Sep 11 | D · derivative | 103,000 | $2.25 | $231,750 | not reported | No | Form 4 |
| Kalali Amir H | Sep 11 | Sep 11 | D · derivative | 121,968 | $4.50 | $548,856 | not reported | No | Form 4 |
| Hoffman John Francis | Sep 11 | Sep 11 | D · derivative | 206,000 | $2.25 | $463,500 | not reported | No | Form 4 |
| Hoffman John Francis | Sep 11 | Sep 11 | D · derivative | 121,968 | $4.50 | $548,856 | not reported | No | Form 4 |
| Fischer Laurent | Sep 11 | Sep 11 | D · derivative | 206,000 | $1.34 | $276,040 | not reported | No | Form 4 |
| Fischer Laurent | Sep 11 | Sep 11 | D · derivative | 103,000 | $2.25 | $231,750 | not reported | No | Form 4 |
| Fischer Laurent | Sep 11 | Sep 11 | D · derivative | 121,968 | $4.50 | $548,856 | not reported | No | Form 4 |
| Faerm Michael E.Chief Financial Officer | Sep 11 | Sep 11 | D · derivative | 1,275,000 | $4.06 | $5,176,500 | not reported | No | Form 4 |
| Faerm Michael E.Chief Financial Officer | Sep 11 | Sep 11 | D · derivative | 285,000 | not reported | not reported | not reported | No | Form 4 |
| Short Glenn FrankChief Scientific Officer | Sep 11 | Sep 11 | D | 42,333 | not reported | not reported | not reported | No | Form 4 |
| Short Glenn FrankChief Scientific Officer | Sep 11 | Sep 11 | D · derivative | 283,280 | $2.44 | $691,203 | not reported | No | Form 4 |
| Short Glenn FrankChief Scientific Officer | Sep 11 | Sep 11 | D · derivative | 329,552 | $5.68 | $1,871,855 | not reported | No | Form 4 |
| Short Glenn FrankChief Scientific Officer | Sep 11 | Sep 11 | D · derivative | 180,000 | $5.54 | $997,200 | not reported | No | Form 4 |
| Short Glenn FrankChief Scientific Officer | Sep 11 | Sep 11 | D · derivative | 71,620 | $2.86 | $204,833 | not reported | No | Form 4 |
| Short Glenn FrankChief Scientific Officer | Sep 11 | Sep 11 | D · derivative | 250,000 | $1.18 | $295,000 | not reported | No | Form 4 |
| Short Glenn FrankChief Scientific Officer | Sep 11 | Sep 11 | D · derivative | 388,000 | $1.84 | $713,920 | not reported | No | Form 4 |
| Short Glenn FrankChief Scientific Officer | Sep 11 | Sep 11 | D · derivative | 757,915 | $1.50 | $1,136,873 | not reported | No | Form 4 |
| Short Glenn FrankChief Scientific Officer | Sep 11 | Sep 11 | D · derivative | 675,000 | $3.76 | $2,538,000 | not reported | No | Form 4 |
| Short Glenn FrankChief Scientific Officer | Sep 11 | Sep 11 | D · derivative | 150,000 | not reported | not reported | not reported | No | Form 4 |
| Barrett Christopher Ryan CaveSee remarks | Sep 11 | Sep 11 | D | 155,066 | not reported | not reported | not reported | No | Form 4 |
| Barrett Christopher Ryan CaveSee remarks | Sep 11 | Sep 11 | D · derivative | 347,000 | $2.44 | $846,680 | not reported | No | Form 4 |
| Barrett Christopher Ryan CaveSee remarks | Sep 11 | Sep 11 | D · derivative | 284,832 | $5.68 | $1,617,846 | not reported | No | Form 4 |
| Barrett Christopher Ryan CaveSee remarks | Sep 11 | Sep 11 | D · derivative | 231,900 | $5.54 | $1,284,726 | not reported | No | Form 4 |
| Barrett Christopher Ryan CaveSee remarks | Sep 11 | Sep 11 | D · derivative | 71,620 | $2.86 | $204,833 | not reported | No | Form 4 |
| Barrett Christopher Ryan CaveSee remarks | Sep 11 | Sep 11 | D · derivative | 400,000 | $1.18 | $472,000 | not reported | No | Form 4 |
| Barrett Christopher Ryan CaveSee remarks | Sep 11 | Sep 11 | D · derivative | 550,000 | $1.84 | $1,012,000 | not reported | No | Form 4 |
| Barrett Christopher Ryan CaveSee remarks | Sep 11 | Sep 11 | D · derivative | 757,915 | $1.50 | $1,136,873 | not reported | No | Form 4 |
| Barrett Christopher Ryan CaveSee remarks | Sep 11 | Sep 11 | D · derivative | 175,000 | $5.20 | $910,000 | not reported | No | Form 4 |
| Barrett Christopher Ryan CaveSee remarks | Sep 11 | Sep 11 | D · derivative | 675,000 | $3.76 | $2,538,000 | not reported | No | Form 4 |
| Barrett Christopher Ryan CaveSee remarks | Sep 11 | Sep 11 | D · derivative | 150,000 | not reported | not reported | not reported | No | Form 4 |
| Johnson Anne NagengastChief Accounting Officer | Sep 11 | Sep 11 | D | 140,045 | not reported | not reported | not reported | No | Form 4 |
| Johnson Anne NagengastChief Accounting Officer | Sep 11 | Sep 11 | D · derivative | 326,416 | $5.68 | $1,854,043 | not reported | No | Form 4 |
| Johnson Anne NagengastChief Accounting Officer | Sep 11 | Sep 11 | D · derivative | 200,000 | $5.54 | $1,108,000 | not reported | No | Form 4 |
| Johnson Anne NagengastChief Accounting Officer | Sep 11 | Sep 11 | D · derivative | 71,620 | $2.86 | $204,833 | not reported | No | Form 4 |
| Johnson Anne NagengastChief Accounting Officer | Sep 11 | Sep 11 | D · derivative | 500,000 | $1.18 | $590,000 | not reported | No | Form 4 |
| Johnson Anne NagengastChief Accounting Officer | Sep 11 | Sep 11 | D · derivative | 550,000 | $1.84 | $1,012,000 | not reported | No | Form 4 |
| Johnson Anne NagengastChief Accounting Officer | Sep 11 | Sep 11 | D · derivative | 757,915 | $1.50 | $1,136,873 | not reported | No | Form 4 |
| Johnson Anne NagengastChief Accounting Officer | Sep 11 | Sep 11 | D · derivative | 525,000 | $3.76 | $1,974,000 | not reported | No | Form 4 |
| Johnson Anne NagengastChief Accounting Officer | Sep 11 | Sep 11 | D · derivative | 117,000 | not reported | not reported | not reported | No | Form 4 |
| Rao SrinivasSee remarks | Sep 11 | Sep 11 | D | 212,942 | not reported | not reported | not reported | No | Form 4 |
| Rao SrinivasSee remarks | Sep 11 | Sep 11 | D | 3,500 | not reported | not reported | not reported | No | Form 4 |
| Rao SrinivasSee remarks | Sep 11 | Sep 11 | D · derivative | 650,795 | $5.68 | $3,696,516 | not reported | No | Form 4 |
| Rao SrinivasSee remarks | Sep 11 | Sep 11 | D · derivative | 217,778 | $2.50 | $544,445 | not reported | No | Form 4 |
| Rao SrinivasSee remarks | Sep 11 | Sep 11 | D · derivative | 2,147,408 | $2.44 | $5,239,676 | not reported | No | Form 4 |
| Rao SrinivasSee remarks | Sep 11 | Sep 11 | D · derivative | 777,400 | $5.65 | $4,392,310 | not reported | No | Form 4 |
| Rao SrinivasSee remarks | Sep 11 | Sep 11 | D · derivative | 600,000 | $1.18 | $708,000 | not reported | No | Form 4 |
| Rao SrinivasSee remarks | Sep 11 | Sep 11 | D · derivative | 800,000 | $1.84 | $1,472,000 | not reported | No | Form 4 |
| Rao SrinivasSee remarks | Sep 11 | Sep 11 | D · derivative | 2,340,000 | $1.75 | $4,095,000 | not reported | No | Form 4 |
| Rao SrinivasSee remarks | Sep 11 | Sep 11 | D · derivative | 1,988,000 | $3.76 | $7,474,880 | not reported | No | Form 4 |
| Rao SrinivasSee remarks | Sep 11 | Sep 11 | D · derivative | 442,000 | not reported | not reported | not reported | No | Form 4 |
| Craig Kevin JamesChief Medical Officer | Sep 11 | Sep 11 | D | 8,437 | not reported | not reported | not reported | No | Form 4 |
| Craig Kevin JamesChief Medical Officer | Sep 11 | Sep 11 | D · derivative | 10,000 | $5.54 | $55,400 | not reported | No | Form 4 |
| Craig Kevin JamesChief Medical Officer | Sep 11 | Sep 11 | D · derivative | 50,400 | $2.86 | $144,144 | not reported | No | Form 4 |
| Craig Kevin JamesChief Medical Officer | Sep 11 | Sep 11 | D · derivative | 28,608 | $1.18 | $33,757 | not reported | No | Form 4 |
| Craig Kevin JamesChief Medical Officer | Sep 11 | Sep 11 | D · derivative | 372,701 | $1.84 | $685,770 | not reported | No | Form 4 |
| Craig Kevin JamesChief Medical Officer | Sep 11 | Sep 11 | D · derivative | 673,808 | $1.50 | $1,010,712 | not reported | No | Form 4 |
| Craig Kevin JamesChief Medical Officer | Sep 11 | Sep 11 | D · derivative | 675,000 | $3.76 | $2,538,000 | not reported | No | Form 4 |
| Craig Kevin JamesChief Medical Officer | Sep 11 | Sep 11 | D · derivative | 150,000 | not reported | not reported | not reported | No | Form 4 |
| Kochendoerfer GerdChief Operating Officer | Sep 11 | Sep 11 | D · derivative | 1,400,000 | $1.60 | $2,240,000 | not reported | No | Form 4 |
| Kochendoerfer GerdChief Operating Officer | Sep 11 | Sep 11 | D · derivative | 675,000 | $3.76 | $2,538,000 | not reported | No | Form 4 |
| Kochendoerfer GerdChief Operating Officer | Sep 11 | Sep 11 | D · derivative | 150,000 | not reported | not reported | not reported | No | Form 4 |
| Hershberg Robert | Jul 7 | Jul 9 | M | 48,858 | $1.35 | $65,958 | 48,858 | Yes | Form 4 |
| Hershberg Robert | Jul 7 | Jul 9 | M | 51,142 | $1.35 | $69,042 | 100,000 | Yes | Form 4 |
| Hershberg Robert | Jul 7 | Jul 9 | S | 100,000 | $4.96 | Sale −$496,000 | 100,000 | Yes | Form 4 |
| Hershberg Robert | Jul 7 | Jul 9 | M · derivative | 48,858 | $1.35 | $65,958 | 48,858 | Yes | Form 4 |
| Hershberg Robert | Jul 7 | Jul 9 | M · derivative | 51,142 | $1.35 | $69,042 | 404,869 | Yes | Form 4 |
| Kochendoerfer GerdChief Operating Officer | Jun 26 | Jun 29 | M | 50,000 | $1.60 | $80,000 | 50,000 | Yes | Form 4 |
| Kochendoerfer GerdChief Operating Officer | Jun 26 | Jun 29 | S | 50,000 | $5.00 | Sale −$250,000 | not reported | Yes | Form 4 |
| Kochendoerfer GerdChief Operating Officer | Jun 26 | Jun 29 | M · derivative | 50,000 | $1.60 | $80,000 | 1,400,000 | Yes | Form 4 |
| Craig Kevin JamesChief Medical Officer | Jun 25 | Jun 29 | M | 33,051 | $1.50 | $49,577 | 41,488 | Yes | Form 4 |
| Craig Kevin JamesChief Medical Officer | Jun 25 | Jun 29 | M | 9,528 | $1.18 | $11,243 | 51,016 | Yes | Form 4 |
| Craig Kevin JamesChief Medical Officer | Jun 25 | Jun 29 | S | 42,579 | $4.51 | Sale −$192,031 | 8,437 | Yes | Form 4 |
| Craig Kevin JamesChief Medical Officer | Jun 25 | Jun 29 | M · derivative | 33,051 | $1.50 | $49,577 | 673,808 | Yes | Form 4 |
| Craig Kevin JamesChief Medical Officer | Jun 25 | Jun 29 | M · derivative | 9,528 | $1.18 | $11,243 | 28,608 | Yes | Form 4 |
| Johnson Sabrina Martucci | Jun 4 | Jun 8 | A · derivative | 121,968 | $4.50 | $548,856 | 121,968 | No | Form 4 |
| Smiley Andrea Heslin | Jun 4 | Jun 8 | A · derivative | 121,968 | $4.50 | $548,856 | 121,968 | No | Form 4 |
| Kalali Amir H | Jun 4 | Jun 8 | A · derivative | 121,968 | $4.50 | $548,856 | 121,968 | No | Form 4 |
| Hoffman John Francis | Jun 4 | Jun 8 | A · derivative | 121,968 | $4.50 | $548,856 | 121,968 | No | Form 4 |
| Hershberg Robert | Jun 4 | Jun 8 | A · derivative | 121,968 | $4.50 | $548,856 | 121,968 | No | Form 4 |
| Fischer Laurent | Jun 4 | Jun 8 | A · derivative | 121,968 | $4.50 | $548,856 | 121,968 | No | Form 4 |
| Braunstein Scott | Jun 4 | Jun 8 | A · derivative | 121,968 | $4.50 | $548,856 | 121,968 | No | Form 4 |
| Braunstein Scott | Jun 4 | Jun 8 | A · derivative | 86,095 | $4.50 | $387,428 | 86,095 | No | Form 4 |
| Angermayer Christian | Jun 4 | Jun 8 | A · derivative | 121,968 | $4.50 | $548,856 | 121,968 | No | Form 4 |
| Craig Kevin JamesChief Medical Officer | Apr 20 | Apr 22 | M | 27,280 | $1.50 | $40,920 | 35,717 | Yes | Form 4 |
| Craig Kevin JamesChief Medical Officer | Apr 20 | Apr 22 | M | 15,299 | $1.84 | $28,150 | 51,016 | Yes | Form 4 |
| Craig Kevin JamesChief Medical Officer | Apr 20 | Apr 22 | S | 42,579 | $5.00 | Sale −$212,895 | 8,437 | Yes | Form 4 |
| Craig Kevin JamesChief Medical Officer | Apr 20 | Apr 22 | M · derivative | 27,280 | $1.50 | $40,920 | 706,859 | Yes | Form 4 |
| Craig Kevin JamesChief Medical Officer | Apr 20 | Apr 22 | M · derivative | 15,299 | $1.84 | $28,150 | 372,701 | Yes | Form 4 |
| Apeiron Investment Group Ltd. | Apr 8 | Apr 10 | M | 46,070 | $1.88 | $86,612 | 46,070 | No | Form 4 |
| Apeiron Investment Group Ltd. | Apr 8 | Apr 10 | M | 410,162 | $1.64 | $672,666 | 456,232 | No | Form 4 |
| Apeiron Investment Group Ltd. | Apr 8 | Apr 10 | M | 103,000 | $1.34 | $138,020 | 559,232 | No | Form 4 |
| Apeiron Investment Group Ltd. | Apr 8 | Apr 10 | M · derivative | 46,070 | $1.88 | $86,612 | 17,930 | No | Form 4 |
| Apeiron Investment Group Ltd. | Apr 8 | Apr 10 | M · derivative | 410,162 | $1.64 | $672,666 | 231,838 | No | Form 4 |
| Apeiron Investment Group Ltd. | Apr 8 | Apr 10 | M · derivative | 103,000 | $1.34 | $138,020 | not reported | No | Form 4 |
| Craig Kevin JamesChief Medical Officer | Mar 20 | Mar 24 | M | 76,224 | $1.18 | $89,944 | 84,661 | Yes | Form 4 |
| Craig Kevin JamesChief Medical Officer | Mar 20 | Mar 24 | M | 23,776 | $1.50 | $35,664 | 108,437 | Yes | Form 4 |
| Craig Kevin JamesChief Medical Officer | Mar 20 | Mar 24 | S | 100,000 | $3.55 | Sale −$355,000 | 8,437 | Yes | Form 4 |
| Craig Kevin JamesChief Medical Officer | Mar 20 | Mar 24 | M · derivative | 76,224 | $1.18 | $89,944 | 38,136 | Yes | Form 4 |
| Craig Kevin JamesChief Medical Officer | Mar 20 | Mar 24 | M · derivative | 23,776 | $1.50 | $35,664 | 734,139 | Yes | Form 4 |
| Faerm Michael E.Chief Financial Officer | Mar 11 | Mar 13 | A · derivative | 1,275,000 | $4.06 | $5,176,500 | 1,275,000 | No | Form 4 |
| Faerm Michael E.Chief Financial Officer | Mar 11 | Mar 13 | A · derivative | 285,000 | $0.00 | $0 | 285,000 | No | Form 4 |
| Craig Kevin JamesChief Medical Officer | Jan 30 | Feb 3 | A · derivative | 675,000 | $3.76 | $2,538,000 | 675,000 | No | Form 4 |
| Craig Kevin JamesChief Medical Officer | Jan 30 | Feb 3 | A · derivative | 150,000 | $0.00 | $0 | 150,000 | No | Form 4 |
| Short Glenn FrankChief Scientific Officer | Jan 30 | Feb 3 | A · derivative | 675,000 | $3.76 | $2,538,000 | 675,000 | No | Form 4 |
| Short Glenn FrankChief Scientific Officer | Jan 30 | Feb 3 | A · derivative | 150,000 | $0.00 | $0 | 150,000 | No | Form 4 |
| Rao SrinivasSee remarks | Jan 30 | Feb 3 | A · derivative | 1,988,000 | $3.76 | $7,474,880 | 1,988,000 | No | Form 4 |
| Rao SrinivasSee remarks | Jan 30 | Feb 3 | A · derivative | 442,000 | $0.00 | $0 | 442,000 | No | Form 4 |
| Kochendoerfer GerdChief Operating Officer | Jan 30 | Feb 3 | A · derivative | 675,000 | $3.76 | $2,538,000 | 675,000 | No | Form 4 |
| Kochendoerfer GerdChief Operating Officer | Jan 30 | Feb 3 | A · derivative | 150,000 | $0.00 | $0 | 150,000 | No | Form 4 |
| Johnson Anne NagengastChief Financial Officer | Jan 30 | Feb 3 | A · derivative | 525,000 | $3.76 | $1,974,000 | 525,000 | No | Form 4 |
| Johnson Anne NagengastChief Financial Officer | Jan 30 | Feb 3 | A · derivative | 117,000 | $0.00 | $0 | 117,000 | No | Form 4 |
| Barrett Christopher Ryan CaveSee remarks | Jan 30 | Feb 3 | A · derivative | 675,000 | $3.76 | $2,538,000 | 675,000 | No | Form 4 |
| Barrett Christopher Ryan CaveSee remarks | Jan 30 | Feb 3 | A · derivative | 150,000 | $0.00 | $0 | 150,000 | No | Form 4 |
| Feilding-Mellen Cosmo | Jan 2 | Jan 6 | S | 39,594 | $3.90 | Sale −$154,417 | 7,663,396 | No | Form 4 |